
1. malar j. 2016 feb 5;15:63. doi: 10.1186/s12936-016-1109-9.

mutations pvdhfr pvdhps genes vivax endemic-malaria areas kota
marudu kalabakan, sabah.

sastu ur(1), abdullah nr(2), norahmad na(3), saat mn(4), muniandy pk(5), jelip
j(6), tikuson m(7), yusof n(8), sidek hm(9).

author information: 
(1)herbal medicine research centre, institute medical research, ministry of
health, jalan pahang, 50588, kuala lumpur, malaysia. umie_1902@yahoo.com.my.
(2)herbal medicine research centre, institute medical research, ministry of
health, jalan pahang, 50588, kuala lumpur, malaysia. noorrain@imr.gov.my.
(3)herbal medicine research centre, institute medical research, ministry of
health, jalan pahang, 50588, kuala lumpur, malaysia. azrina@imr.gov.my.
(4)herbal medicine research centre, institute medical research, ministry of
health, jalan pahang, 50588, kuala lumpur, malaysia. mnfarhan@imr.gov.my.
(5)herbal medicine research centre, institute medical research, ministry of
health, jalan pahang, 50588, kuala lumpur, malaysia. prem_khs@hotmail.com.
(6)sabah state health department, level 3, rumah persekutuan, jalan mat salleh,
88590, kota kinabalu, sabah, malaysia. drjenarun@gmail.com.
(7)district health office kota marudu, po box 421, 89108, kota marudu, sabah,
malaysia. tmoizin@yahoo.com.
(8)district health office kota marudu, po box 421, 89108, kota marudu, sabah,
malaysia. hazimnsy@yahoo.com.
(9)faculty science technology, school bioscience biotechnology,
universiti kebangsaan malaysia, 43600, bangi, malaysia.
hasidahmohdsidek@yahoo.com.

background: malaria cases persist remote areas sabah sarawak
despite ongoing largely successful malaria control programme conducted by
the vector borne disease control programme, ministry health, malaysia. point
mutations genes encode two enzymes involved folate
biosynthesis pathway, dihydrofolate reductase (dhfr) dihydropteroate synthase
(dhps) enzymes confer resistance pyrimethamine sulfadoxine respectively,
in plasmodium falciparum p. vivax. aim current study to
determine mutation pvdhfr codon 13, 33, 57, 58, 61, 117, 173
and pvdhps genes codon 383 553, potentially associated with
resistance pyrimethamine sulfadoxine p. vivax samples sabah.
methods: every individual screened presence malaria infection using 
commercial rapid dipstick assay, paramax-3â„¢ (zephyr biomedical, india).
individuals tested positive p. vivax blood collected parasite dna
extracted. pvdhfr pvdhps genes amplified nested-pcr. restriction 
fragment length polymorphism (rflp) carried detection specific
mutations pvdhfr codons 13leu, 33leu, 57ile/leu, 58arg, 61met, 117asn/thr, 
and 173leu pvdhps codons 383gly 553gly. pcr-rflp products were
analysed using agilent 2100 bioanalyzer (agilent technology, as).
results: total 619 2119 individuals kalabakan kota marudu,
respectively participated study. kalabakan kota marudu, 9.37 and
2.45 % tested positive malaria positivity p. vivax infection
was 4.2 0.52 %, respectively. mutation observed codon 13, 33 and
173 pvdhfr codon 553 pvdhps gene samples kalabakan kota 
marudu. one-hundred per cent mutations pvdhfr 57leu 117thr.
mutation 58arg 61met observed higher kota marudu 72.73 %.
mutation 383gly pvdhps highest kalabakan 80.77 %. are
four distinct haplotypes pvdhfr/pvdhps combination.
conclusions: presence triple quintuple mutation combination suggest
that p. vivax isolates exhibit high degree resistant sulfadoxine,
pyrimethamine sulfadoxine-pyrimethamine combination therapy.

doi: 10.1186/s12936-016-1109-9 
pmcid: pmc4743234
pmid: 26850038  [indexed medline]

